Home
Glenmark Life Sciences

Glenmark Life Sciences Market Share Analysis for July 2026

Alivus Life Sciences is a leading developer and manufacturer of select high value, non-commoditized Active Pharmaceutical Ingredients (APIs)

Health > Biotechnology and Pharmaceuticals

Domainglenmarklifesciences.com

Year Founded2011

Employees1001 - 5000

Annual Revenue$200M - $500M

Glenmark Life Sciences

Glenmark Life Sciences (including company regionals)

glenmarklifesciences.com

See more website traffic and engagement information

Glenmark Life Sciences Revenue up to July 2026 is 200M - 500M

revenue generated by Glenmark Life Sciences top domains

Glenmark Life Sciences top domains revenue over 3 years

Revenue for Glenmark Life Sciences top domains

glenmarklifesciences.com200M - 500M

See more with Sales Intelligence

Total visits to Glenmark Life Sciences's top domains

Understand Glenmark Life Sciences market share and potential market reach.

Total visits last 3 months

No Data to Display

Avg. visit duration in Glenmark Life Sciences's top domains

Analyze Glenmark Life Sciences engagement metrics.

Average visit duration last 3 months

No Data to Display

Avg. pageviews on Glenmark Life Sciences's top domains

See how Glenmark Life Sciences keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

No Data to Display

Glenmark Life Sciences top competitors by domain

Looks like there’s not enough data here

No Data to Display

Top technologies used by Glenmark Life Sciences

These are the website technologies, by industry, used by Glenmark Life Sciences top domains

Payment & Currencies (6)

Euro

Advertising (2)

DoubleClick

Mobile (2)

Meta Viewport

Widget (2)

reCAPTCHA

More Technologies

3

See all

News & Signals from Glenmark Life Sciences

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsGlenmark Life Sciences Limited receives award Closure Notice for Ankleshwar.Glenmark Life Sciences Limited received Closure Notice for Ankleshwar facility by The Gujarat Pollution Control Board.

NewsGlenn Saldanha left Glenmark Life Sciences Limited as Chairman on Mar 6th '24.Glenn Saldanha resigns as chairman of Glenmark Life Sciences.

NewsNirma Limited acquired Glenmark Life Sciences Limited for $900M on Sep 1st '23.In September this year, Nirma had announced that it would acquire 75 per cent stake in Glenmark Life Sciences for ₹7,500 crore.